{"name":"Fundación Santiago Dexeus Font","slug":"fundaci-n-santiago-dexeus-font","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"oncology","drugs":[{"name":"rhFSH+rhLH","genericName":"rhFSH+rhLH","slug":"rhfsh-rhlh","indication":"Infertility in women undergoing assisted reproductive technology (ART)","status":"marketed"},{"name":"Ovulation triggering with GnRH-a","genericName":"Ovulation triggering with GnRH-a","slug":"ovulation-triggering-with-gnrh-a","indication":"Other","status":"marketed"},{"name":"rhFSH","genericName":"rhFSH","slug":"rhfsh","indication":"Infertility in women undergoing assisted reproductive technology (ART)","status":"marketed"},{"name":"Cellular Matrix / A-CP-HA Kit","genericName":"Cellular Matrix / A-CP-HA Kit","slug":"cellular-matrix-a-cp-ha-kit","indication":"Tissue regeneration and repair (specific indications not publicly detailed)","status":"marketed"},{"name":"Ovarian Stimulation with CC+rFSH","genericName":"Ovarian Stimulation with CC+rFSH","slug":"ovarian-stimulation-with-cc-rfsh","indication":"Ovarian stimulation for assisted reproductive technology (ART) in women with infertility","status":"marketed"},{"name":"Ovarian Stimulation with rFSH","genericName":"Ovarian Stimulation with rFSH","slug":"ovarian-stimulation-with-rfsh","indication":"Ovarian stimulation for assisted reproductive technology (ART) including in vitro fertilization (IVF)","status":"marketed"},{"name":"Ovulation triggering with GnRH-a+rhCG","genericName":"Ovulation triggering with GnRH-a+rhCG","slug":"ovulation-triggering-with-gnrh-a-rhcg","indication":"Ovulation triggering in assisted reproductive technology (ART) cycles, including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI)","status":"marketed"}]}],"pipeline":[{"name":"rhFSH+rhLH","genericName":"rhFSH+rhLH","slug":"rhfsh-rhlh","phase":"marketed","mechanism":"rhFSH and rhLH are recombinant human gonadotropins that stimulate follicle development and ovulation in women undergoing fertility treatment.","indications":["Infertility in women undergoing assisted reproductive technology (ART)","Anovulation and ovulatory disorders"],"catalyst":""},{"name":"Ovulation triggering with GnRH-a","genericName":"Ovulation triggering with GnRH-a","slug":"ovulation-triggering-with-gnrh-a","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"rhFSH","genericName":"rhFSH","slug":"rhfsh","phase":"marketed","mechanism":"rhFSH (recombinant human follicle-stimulating hormone) stimulates the growth and maturation of ovarian follicles in women by binding to FSH receptors on granulosa cells.","indications":["Infertility in women undergoing assisted reproductive technology (ART)","Anovulation and ovulatory disorders in women"],"catalyst":""},{"name":"Cellular Matrix / A-CP-HA Kit","genericName":"Cellular Matrix / A-CP-HA Kit","slug":"cellular-matrix-a-cp-ha-kit","phase":"marketed","mechanism":"A cellular matrix product combining autologous cells with hyaluronic acid to promote tissue regeneration and repair.","indications":["Tissue regeneration and repair (specific indications not publicly detailed)"],"catalyst":""},{"name":"Ovarian Stimulation with CC+rFSH","genericName":"Ovarian Stimulation with CC+rFSH","slug":"ovarian-stimulation-with-cc-rfsh","phase":"marketed","mechanism":"CC+rFSH is a combination hormonal therapy that stimulates ovarian follicle development by blocking negative feedback (clomiphene citrate) while directly stimulating follicle growth (recombinant FSH).","indications":["Ovarian stimulation for assisted reproductive technology (ART) in women with infertility"],"catalyst":""},{"name":"Ovarian Stimulation with rFSH","genericName":"Ovarian Stimulation with rFSH","slug":"ovarian-stimulation-with-rfsh","phase":"marketed","mechanism":"Recombinant follicle-stimulating hormone (rFSH) stimulates the growth and maturation of ovarian follicles to produce multiple eggs for assisted reproductive procedures.","indications":["Ovarian stimulation for assisted reproductive technology (ART) including in vitro fertilization (IVF)","Ovulation induction in anovulatory women"],"catalyst":""},{"name":"Ovulation triggering with GnRH-a+rhCG","genericName":"Ovulation triggering with GnRH-a+rhCG","slug":"ovulation-triggering-with-gnrh-a-rhcg","phase":"marketed","mechanism":"GnRH agonist priming followed by recombinant human chorionic gonadotropin (rhCG) triggers final oocyte maturation and ovulation in assisted reproductive technology cycles.","indications":["Ovulation triggering in assisted reproductive technology (ART) cycles, including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":7,"phaseCounts":{"marketed":7},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}